苹果酸舒尼替尼,CAS 登记号 341031-54-7,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
有机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 苹果酸舒尼替尼 的 CAS 号:341031-54-7,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Sunitinib malate · CAS 341031-54-7 · C26H33FN4O7. UNII LVX8N1UT73.
| CAS Registry Number | 341031-54-7 |
|---|---|
| PubChem CID | 6456015 |
| Molecular formula | C26H33FN4O7 |
| IUPAC name | N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid |
| UNII (FDA) | LVX8N1UT73 |
| Molecular Weight | 532.6 |
|---|---|
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 10 |
| Exact Mass | 532.23332757 |
| Monoisotopic Mass | 532.23332757 |
| Topological Polar Surface Area | 172 |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 765 |
| Reported hazard statements | H360 (93.8%), H372 (97.9%), H400 (12.5%), H410 (12.5%) |
|---|
H360 (93.8%): May damage fertility or the unborn child [Danger Reproductive toxicity]
H372 (97.9%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]
Sunitinib malate; 341031-54-7; SU011248 L-malate salt; PHA-290940AD; sunitinib L-malate; SU010398; SU-011248 L-malate salt; DTXSID4046492; LVX8N1UT73; SU-010398; DTXCID801476195; NSC736511; RefChem:56081; Sutent; Sunitinib malate [USAN]; MFCD08282795
CAS 341031-54-7; molecular formula C26H33FN4O7; molecular weight — g/mol.
Sunitinib malate, 341031-54-7, SU011248 L-malate salt, PHA-290940AD, sunitinib L-malate, SU010398.
Hazard statements reported: H360, H372, H400, H410.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.